Medicis Pharma (MRX) Posts Q3 non-GAAP EPS of $0.58, Tops by 1c; Guides Q410, FY10 EPS, Revs
Tweet Send to a Friend
Medicis Pharmaceutical Corp. (NYSE: MRX) reports Q3 non-GAAP EPS of $0.58, 1 cent better than the consensus of $0.57 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
